Clinical Trials Insight: 700033367

Trial Profile

Clinical Trials Insight: 700033367

Recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2008

At a glance

  • Drugs NU 172 (Primary)
  • Indications Thrombosis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Nuvelo
  • Most Recent Events

    • 04 Jun 2008 Status changed from planning to recruiting according to Nuvelo media release.
    • 04 Jun 2008 Enrollment has begun according to Nuvelo media release.
    • 08 May 2008 This trial is expected to be completed and top-line data presented in the third quarter of 2008, reported by Nuvelo.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top